[HTML][HTML] SARS-CoV-2 infection and multi-organ system damage: A review

AA Rabaan, S Smajlović, H Tombuloglu… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
The SARS-CoV-2 infection causes COVID-19, which has affected approximately six hundred
million people globally as of 8 2022. Organs and cells harboring angiotensin-converting …

An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic

S Jamwal, A Gautam, J Elsworth, M Kumar, R Chawla… - Life sciences, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an unprecedented disease caused by
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …

[HTML][HTML] New understanding of the damage of SARS-CoV-2 infection outside the respiratory system

Y Zhang, X Geng, Y Tan, Q Li, C Xu, J Xu, L Hao… - Biomedicine & …, 2020 - Elsevier
Since early December 2019, a number of pneumonia cases associated with unknown
coronavirus infection were identified in Wuhan, China, and many additional cases were …

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells

S Appelberg, S Gupta… - Emerging microbes & …, 2020 - Taylor & Francis
How severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections engage
cellular host pathways and innate immunity in infected cells remains largely elusive. We …

COVID-19 and cardiovascular diseases

F Liu, F Liu, L Wang - Journal of molecular cell biology, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) remains a global public health
emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Gene expression profiling reveals the shared and distinct transcriptional signatures in human lung epithelial cells infected with SARS-CoV-2, MERS-CoV, or …

PK Jha, A Vijay, A Halu, S Uchida… - Frontiers in cardiovascular …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus for
the current global pandemic known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 …

Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus …

J Bhatnagar, J Gary, S Reagan-Steiner… - The Journal of …, 2021 - academic.oup.com
Background The coronavirus disease 2019 (COVID-19) pandemic continues to produce
substantial morbidity and mortality. To understand the reasons for the wide-spectrum …

COVID-19 and multiorgan response

S Zaim, JH Chong, V Sankaranarayanan… - Current problems in …, 2020 - Elsevier
Since the outbreak and rapid spread of COVID-19 starting late December 2019, it has been
apparent that disease prognosis has largely been influenced by multiorgan involvement …

[HTML][HTML] SARS-CoV-2 and COVID-19: The most important research questions

KS Yuen, ZW Ye, SY Fung, CP Chan, DY Jin - Cell & bioscience, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. Here we …

[HTML][HTML] COVID-19 and multiorgan failure: A narrative review on potential mechanisms

T Mokhtari, F Hassani, N Ghaffari, B Ebrahimi… - Journal of molecular …, 2020 - Springer
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …